Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 14.98% is 123% above its 5-year average of 6.72%, near the high end of its 5-year range (4.77%–14.98%).
146.58% above its 12-month average of 6.07%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 2.76%.
RETURN ON ASSETS (ROA)
14.98%
RETURN ON ASSETS (ROA) AVG TTM
6.07%
RETURN ON ASSETS (ROA) AVG 3Y
5.42%
RETURN ON ASSETS (ROA) AVG 5Y
6.72%
RETURN ON ASSETS (ROA) AVG 10Y
9.18%
RETURN ON ASSETS (ROA) AVG 15Y
9.73%
RETURN ON ASSETS (ROA) AVG 20Y
10.09%
CURRENT VS TTM AVG
+146.58%
CURRENT VS 3Y AVG
+176.13%
CURRENT VS 5Y AVG
+122.97%
CURRENT VS 10Y AVG
+63.20%
CURRENT VS 15Y AVG
+54.03%
CURRENT VS 20Y AVG
+48.51%
SECTOR MEDIAN · HEALTHCARE
-30.47%
median of 682 covered companies
CURRENT VS SECTOR MEDIAN
+149.16%
vs the sector median at left
Healthcare Services Group, Inc.
Market Cap
$1.46B
Return on Assets (ROA)
14.98%
TTM Avg
6.07%
3Y Avg
5.42%
5Y Avg
6.72%
Market Cap
$1.47B
Return on Assets (ROA)
-25.13%
TTM Avg
-5.66%
3Y Avg
-57.10%
5Y Avg
-57.10%
Market Cap
$1.49B
Return on Assets (ROA)
-4.89%
TTM Avg
-0.43%
3Y Avg
-0.87%
5Y Avg
-1.37%
Market Cap
$1.44B
Return on Assets (ROA)
61.75%
TTM Avg
-16.82%
3Y Avg
-22.73%
5Y Avg
-17.45%
Market Cap
$1.49B
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.43B
Return on Assets (ROA)
-21.52%
TTM Avg
-21.52%
3Y Avg
-21.52%
5Y Avg
-21.52%
Market Cap
$1.50B
Return on Assets (ROA)
-16.72%
TTM Avg
-18.71%
3Y Avg
-15.50%
5Y Avg
-12.14%
Market Cap
$1.41B
Return on Assets (ROA)
-89.60%
TTM Avg
418.97%
3Y Avg
177.41%
5Y Avg
100.38%
Market Cap
$1.51B
Return on Assets (ROA)
6.64%
TTM Avg
5.09%
3Y Avg
3.45%
5Y Avg
4.26%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Services Group, Inc. (HCSG) | $1.46B | 14.98% | 6.07% | 5.42% | 6.72% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.47B | -25.13% | -5.66% | -57.10% | -57.10% |
| Certara, Inc. (CERT)vs › | $1.49B | -4.89% | -0.43% | -0.87% | -1.37% |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | 61.75% | -16.82% | -22.73% | -17.45% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.43B | -21.52% | -21.52% | -21.52% | -21.52% |
| GH Research PLC (GHRS)vs › | $1.50B | -16.72% | -18.71% | -15.50% | -12.14% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.41B | -89.60% | 418.97% | 177.41% | 100.38% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.51B | 6.64% | 5.09% | 3.45% | 4.26% |
| The Pennant Group, Inc. (PNTG)vs › | $1.42B | 3.12% | 3.19% | 2.54% | 2.30% |
ROA
15.0%
ROE
23.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 7.31% |
| 2024-12-31 | 4.84% |
| 2023-12-31 | 4.78% |
| 2022-12-31 | 4.77% |
| 2021-12-31 | 6.17% |
| 2020-12-31 | 12.44% |
| 2019-12-31 | 8.84% |
| 2018-12-31 | 12.06% |
| 2017-12-31 | 13.05% |
| 2016-12-31 | 14.65% |
| 2015-12-31 | 12.06% |
| 2014-12-31 | 4.65% |
| 2013-12-31 | 11.08% |
| 2012-12-31 | 13.35% |
| 2011-12-31 | 13.17% |
| 2010-12-31 | 12.39% |
| 2009-12-31 | 11.41% |
| 2008-12-31 | 10.71% |
| 2007-12-31 | 12.15% |
| 2006-12-31 | 11.81% |
| 2005-12-31 | 10.13% |
| 2004-12-31 | 8.80% |
| 2003-12-31 | 6.86% |
| 2002-12-31 | 6.43% |
| 2001-12-31 | 5.82% |
| 2000-12-31 | 5.16% |
| 1999-12-31 | 5.61% |
| 1998-12-31 | 9.56% |
| 1997-12-31 | 6.95% |
| 1996-12-31 | 7.99% |
